Similar findings were obtained when a FAP vaccine was employed to stimulate the immune system against CAF, enabling CD8+ infiltration coupled to a decrease in macrophage infiltration in different pre-clinical tumor models [113]. The gene discussed is FAP; the disease is neoplasm.